SHK suppresses NF-κB-regulated gene products and pyruvate kinase-M2 (PKM2), induces immunogenic cell death, and inhibits cancer glucose metabolism [72,73,74], while JQ1 selectively inhibits the Bromodomain-containing protein 4 (BRD4) signaling pathway [75]. The gene discussed is BRD4; the disease is cancer.